Annual Report on Continuous Supervision for 2025 of Shandong Lukang Pharmaceutical Co., Ltd. by China International Capital Corporation Limited

About this update from Shandong Lukang Pharmaceutical Co., Ltd. Class A

Annual Report on Continuous Supervision for 2025 of Shandong Lukang Pharmaceutical Co., Ltd. by China International Capital Corporation Limited The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shandong Lukang Pharmaceutical Co., Ltd. Class A